Miguel A Molina-Vila, Clara Mayo de-Las-Casas, Jordi Bertran-Alamillo, Nuria Jordana-Ariza, María González-Cao, Rafael Rosell
Testing of tumor tissue remains the recommended method for detecting the presence of somatic mutations in human malignancies. V600E is the most frequent somatic point mutation in metastatic melanoma, providing a unique molecular marker for this malignancy. In addition, tumors carrying this mutation are primary candidates for BRAF-targeted therapy. Although metastatic melanoma patients usually have sufficient tumor tissue available for genetic analyses, the detection of V600E in blood can have prognostic and predictive value...
November 2015: Annals of Translational Medicine